The chasm between the Nasdaq Compound and its rival benchmarks in the first half of 2020 has been very similar between Olympic sprinter Usain Bolt and everyone else in the world. The tech-laden index has enjoyed a growing advantage between itself and the Dow Jones Industrial Average USA: DJIA and …
Read More »
Gilead Sciences Inc.’s COVID-19 drug remdesivir will cost much less than Wall Street analysts had predicted in a move that likely points to a more measured and responsible approach to the price of treatments and vaccines during the pandemic. Gilead GILD Shares, It gained 0.9% in trading on Monday following …
Read More »
The grim milestones of 10 million global coronavirus cases and more than 500,000 deaths, along with spikes in various U.S. states, have not deterred investors on Monday. US stocks rose in early trading, despite further indications that a second wave may be just around the corner. The Dow Jones Industrial …
Read More »
The grim milestones of 10 million global coronavirus cases and more than 500,000 deaths, along with spikes in various U.S. states, have not deterred investors on Monday. US stock futures were on the upside before the open, despite further indications that a second wave may be just around the corner. …
Read More »
European stocks struggled for direction when a new week began on Monday, and investor focus remained on rising US coronavirus infection rates. Yielding past gains, the Stoxx Europe 600 SXXP Index, -0.01% it held steady at 358.09, after a 1.9% drop last week. The German DAX + 0.40% rose 0.2%, …
Read More »